These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 17702097)

  • 21. Interdisciplinary assessment and diagnostic algorithm: The role of the cardiologist.
    Rosano GMC; Vitale C; Maltese G
    Diabetes Res Clin Pract; 2021 Jun; 176():108851. PubMed ID: 33957142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacologic management of patients with both heart failure and diabetes.
    MacDonald MR; Petrie MC; Fisher M; McMurray JJ
    Curr Heart Fail Rep; 2009 Jun; 6(2):126-32. PubMed ID: 19486597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myocardial performance index, a Doppler-derived index of global left ventricular function, predicts congestive heart failure in elderly men.
    Arnlöv J; Ingelsson E; Risérus U; Andrén B; Lind L
    Eur Heart J; 2004 Dec; 25(24):2220-5. PubMed ID: 15589639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis.
    Pantalone KM; Kattan MW; Yu C; Wells BJ; Arrigain S; Jain A; Atreja A; Zimmerman RS
    Acta Diabetol; 2009 Jun; 46(2):145-54. PubMed ID: 19194648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metformin usages in women with heart failure.
    Kittisupamongkol W
    Am J Obstet Gynecol; 2009 Jul; 201(1):e18; author reply e18-9. PubMed ID: 19306964
    [No Abstract]   [Full Text] [Related]  

  • 26. Age-related hemodynamic, renal, and hormonal differences among patients with congestive heart failure.
    Cody RJ; Torre S; Clark M; Pondolfino K
    Arch Intern Med; 1989 May; 149(5):1023-8. PubMed ID: 2655542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of acute hyperglycaemia, long-term glycaemic control and insulin on endothelial dysfunction and inflammation in Type 1 diabetic patients with different characteristics.
    Ceriello A; Esposito K; Ihnat M; Thorpe J; Giugliano D
    Diabet Med; 2010 Aug; 27(8):911-7. PubMed ID: 20653749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Heart insufficiency in the elderly].
    Duc P; Cohen-Solal A; Legrain S; Aumont MC
    Ann Cardiol Angeiol (Paris); 2001; 50(7-8):426-33. PubMed ID: 12555637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Congestive heart failure in the elderly: the Cardiovascular Health Study.
    Mathew ST; Gottdiener JS; Kitzman D; Aurigemma G
    Am J Geriatr Cardiol; 2004; 13(2):61-8. PubMed ID: 15010652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure.
    Suskin N; McKelvie RS; Burns RJ; Latini R; Pericak D; Probstfield J; Rouleau JL; Sigouin C; Solymoss CB; Tsuyuki R; White M; Yusuf S
    Eur Heart J; 2000 Aug; 21(16):1368-75. PubMed ID: 10952826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Congestive heart failure.
    Gerstenblith G
    Cardiovasc Clin; 1981; 12(1):131-44. PubMed ID: 7285038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin resistance syndrome predicts coronary heart disease events in elderly type 2 diabetic men.
    Kuusisto J; Lempiäinen P; Mykkänen L; Laakso M
    Diabetes Care; 2001 Sep; 24(9):1629-33. PubMed ID: 11522711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The University Group Diabetes Program. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. V. Evaluation of pheniformin therapy.
    Diabetes; 1975; 24 Suppl 1():65-184. PubMed ID: 1090475
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical characteristics, left and right ventricular ejection fraction, and long-term prognosis in patients with non-insulin-dependent diabetes surviving an acute myocardial infarction.
    Melchior T; Gadsbøll N; Hildebrandt P; Køber L; Torp-Pedersen C
    Diabet Med; 1996 May; 13(5):450-6. PubMed ID: 8737027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetic cardiomyopathy. A unique entity or a complication of coronary artery disease?
    Bell DS
    Diabetes Care; 1995 May; 18(5):708-14. PubMed ID: 8586013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peroxisome proliferator activator receptors (PPAR), insulin resistance, and cardiomyopathy: friends or foes for the diabetic patient with heart failure?
    Nikolaidis LA; Levine TB
    Cardiol Rev; 2004; 12(3):158-70. PubMed ID: 15078585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Congestive heart failure in the elderly.
    Walker JE
    Conn Med; 1993 May; 57(5):293-8. PubMed ID: 8319445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diabetes mellitus and chronic heart failure].
    Spinar J; Vítovec J
    Vnitr Lek; 2003 Dec; 49(12):927-34. PubMed ID: 15040157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Which antidiabetic agent in a patient with type 2 diabetes and heart failure ?].
    Scheen AJ; Paquot N
    Rev Med Liege; 2017 Sep; 72(9):423-428. PubMed ID: 28892319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A clinical risk score for heart failure in patients with type 2 diabetes and macrovascular disease: an analysis of the PROactive study.
    Pfister R; Cairns R; Erdmann E; Schneider CA
    Int J Cardiol; 2013 Jan; 162(2):112-6. PubMed ID: 21636144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.